And efficient method for reprogramming blood to induced pluripotent stem cells
AssigneeCedars-Sinai Medical Center
InventorsDhruv Sareen, Loren A. Ornelas, Clive Svendsen
Life of this patent
Estimating the term…
Loading patent…
AssigneeCedars-Sinai Medical Center
InventorsDhruv Sareen, Loren A. Ornelas, Clive Svendsen
Estimating the term…
Described herein are methods and compositions related to generation of induced pluripotent stem cells (iPSCs). Improved techniques for establishing highly efficient, reproducible reprogramming using non-integrating episomal plasmid vectors. Using the described reprogramming protocol, one is able to consistently reprogram non-T cells with close to 100% success from non-T cell or non-B cell sources. Further advantages include use of a defined reprogramming media E7 and using defined clinically compatible substrate recombinant human L-521. Generation of iPSCs from these blood cell sources allows for recapitulation of the entire genomic repertoire, preservation of genomic fidelity and enhanced genomic stability.
A blood cell derived induced pluripotent stem cell (BC-iPSC) line,
A blood cell derived induced pluripotent stem cell (BC-iPSC) line,
Dependencies are inferred from the claim text.